CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone ...

The pleural effusion that was initially drained recurred after two weeks but subsequently resolved on follow‑up imaging as part of the patient’s response to chemotherapy. Repeat LDH measurement was ...

Debi Weiss thought her fatigue and weakness was a seasonal illness, but her condition quickly worsened.

NICE recommends epcoritamab for relapsed follicular lymphoma, offering a new option after multiple lines of therapy.

Mount Gambier man Ben Whitehead's world changed when he was diagnosed with lymphoma and initially given three months to live, but he's doing his best to stay positive.

Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors This knowledge can be used to ...

Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is a rare subtype of non-Hodgkin lymphoma that frequently presents with multiorgan involvement. We report a diagnostically challenging ...

Detailed price information for Citius Pharmaceuticals Inc (CTXR-Q) from The Globe and Mail including charting and trades.

While chemotherapy and radiation therapy are standard treatments for cancer newer advancements like CAR T-Cell Therapy are emerging out as transformative options A hematology oncologist shares procedu ...